Arm vs. Credo Technology Group: Which Semiconductor Stock Is a Better Buy in 2026?

Credo Technology is favored over Arm for 2026 after FY2026 revenue surged 205.7% to nearly $1.3B and net income reached $472.3M, lifting net margin to 35.4% from 11.9%. Credo trades at 26.5x forward P/E and 23.2x sales, versus Arm at 102.9x and 49.8x, respectively, while management has guided for more than 85% full-year revenue growth. Arm remains a durable semiconductor-IP franchise, reporting FY2026 revenue growth of 22.8% to nearly $4.9B, but its premium valuation and slightly lower 18.4% margin temper the investment case; Credo's principal risks are heavy customer concentration and sole-source manufacturing dependence on TSMC.

Analysis

CRDO's valuation discount is unlikely to be durable if its current growth persists, but the market is correctly assigning a concentration haircut: a single hyperscaler order pause can create an abrupt revenue air pocket because connectivity components are purchased in discrete cluster-build cycles. The key earnings variable is not aggregate AI capex but the mix of scale-up versus scale-out architectures; higher port speeds and optical interconnect density favor CRDO, while a shift toward vertically integrated networking designs benefits AVGO and potentially compresses CRDO's gross-margin premium. Over the next 1-3 months, hyperscaler capex commentary and CRDO's customer-concentration disclosure matter more than headline AI demand.

ARM has superior duration but less favorable near-term asymmetry. Its licensing pipeline can monetize custom CPU adoption at hyperscalers, yet royalty realization lags design wins by multiple product cycles, leaving the stock exposed to a de-rating if revenue growth merely normalizes while its premium multiple remains intact. The more important structural risk is that RISC-V adoption need not displace Arm broadly to matter: share losses in price-sensitive edge, automotive, or China-adjacent applications could lower long-run royalty mix and challenge the embedded durability premium over 6-18 months.

The non-obvious beneficiary of CRDO's success is TSM: advanced-node and packaging demand rises with each high-speed interconnect content increase, whereas MRVL and AVGO are the cleaner competitive hedges against a customer-specific CRDO disappointment. Do not treat reported cash conversion as equivalent to owner earnings without tracking dilution; elevated SBC can turn multiple expansion into per-share stagnation even if operating results remain strong. This is routine bullish commentary rather than an independent demand datapoint, so position sizing should await the next guidance and customer-capex read-through.

Key Decisions for Investors

• Initiate a 1-3 month relative-value position: long CRDO / short ARM in equal dollar amounts only after CRDO confirms next-quarter revenue guidance and no incremental customer concentration. Target 15-20% relative upside if execution remains intact; exit if CRDO guides below consensus or discloses a meaningful reduction in a top-customer program.
• For a lower-beta expression, own TSM against a basket short of CRDO and MRVL only if AI infrastructure orders translate into foundry utilization or advanced-packaging guidance. The trade is invalidated by weaker leading-edge wafer demand or a Taiwan geopolitical risk premium widening materially.
• Avoid adding outright ARM at the current valuation until a licensing/royalty catalyst demonstrates accelerated data-center monetization. A more attractive entry requires either a material multiple reset or evidence that royalty growth is outpacing licensing growth for two consecutive quarters.
• Set alerts around ORCL and MSFT capex, networking, and supply-chain commentary over the next two reporting cycles. Any indication of slower cluster deployments is a near-term short catalyst for CRDO; evidence of rising 800G/1.6T optical content supports maintaining the long leg.